Ads
related to: pfizer
Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Reuters via Yahoo News· 2 hours agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 6 hours agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 9 hours agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...
Paxlovid Fails to Quell Long Covid Symptoms in Stanford Study
Bloomberg· 2 hours agoA 15-day course of Pfizer Inc.’s antiviral Paxlovid didn’t provide significant relief for long Covid...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 3 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
2 Dividend Stocks Billionaires Are Buying: Should You?
The Motley Fool via AOL· 7 hours agoIt's essential to do some research of our own. With that said, let's look at two dividend stocks that at least a couple of billionaires bought during the last quarter: Pfizer
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 3 hours agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 4 hours agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Pfizer Stock: Surging Cancer Rates Will Boost Revenues (NYSE:PFE)
Seeking Alpha· 12 hours agoAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the...